Dual-Target SARS-CoV-2

STAR Complete

Test Benefits

The LumiraDx Dual-Target SARS-CoV-2 STAR Complete multiplex assay is intended for the detection and differentiation of nucleic acid from two distinct genes from the SARS-CoV-2 genome in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19.

  • Reliable and robust performance when compared to traditional RT-PCR tests.
  • Direct amplification within 20 minutes drives lab’s efficiency and productivity.
  • Two distinct genes to meet regions regulatory compliance.
  • Based on in silico analysis we confirm detection of all known circulating variants including Omicron, Omicron B.2 and Delta.

Test Workflows

Dual-Target SARS-CoV-2 STAR Complete - Test Workflows


Dual-Target SARS-CoV-2 STAR Complete - Performance

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.